MARK2 and cardiac hypertrophy: A previous study found that BRG1 attenuated exercise-induced physiological myocardial hypertrophy by inhibiting pressure overload-induced histone deacetylase 2 activation and serine/threonine kinase/glycogen synthase kinase 3β phosphorylation [24].